Clinical Trials

NCT IdNCT04871997
TitleA Real-world Study: Efficacy and Safety of Anlotinib for Advanced Non-small Cell Lung Cancer(NSCLC)
ConditionNSCLC
StudyTypeObservational
OrganizationTongji Hospital
Sponsor/CollaboratorsQian Chu
StatusRecruiting
GenderAll
AgeGroupAdult
Older Adult
Location (with distance)
  • Hubei province, Wuhan, 430030 , China
DescriptionA real-world study: Efficacy and safety of Anlotinib for advanced non-small cell lung cancer:This study aims to observe and explore the efficacy and safety of anlotinib in patients with advanced non-small cell lung cancer in the real world, and to summarize the treatment experience of a broad population.